000			02034 a2200553 4500
005			20250513131426.0
264		0	_c19971217
008			199712s 0 0 eng d
022			_a0002-9513
024	7		_a10.1152/ajplung.1997.273.5.L950 _2doi
040			_aNLM _beng _cNLM
100	1		_aSheridan, B C
245	0	0	_aKATP channels contribute to beta- and adenosine receptor-mediated pulmonary vasorelaxation. _h[electronic resource]
260			_bThe American journal of physiology _c11 1997
300			_aL950-6 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aATP-Binding Cassette Transporters
650	0	4	_aAcetylcholine _xpharmacology
650	0	4	_aAdenosine _xpharmacology
650	0	4	_aAdenylyl Cyclases _xmetabolism
650	0	4	_aAnimals
650	0	4	_aColforsin _xpharmacology
650	0	4	_aCromakalim _xpharmacology
650	0	4	_aCyclic AMP _xmetabolism
650	0	4	_aCyclic GMP _xmetabolism
650	0	4	_aGlyburide _xpharmacology
650	0	4	_aIn Vitro Techniques
650	0	4	_aIsoproterenol _xpharmacology
650	0	4	_aKATP Channels
650	0	4	_aKinetics
650	0	4	_aMale
650	0	4	_aMuscle Relaxation _xdrug effects
650	0	4	_aMuscle, Smooth, Vascular _xdrug effects
650	0	4	_aNitroprusside _xpharmacology
650	0	4	_aPotassium Channels _xphysiology
650	0	4	_aPotassium Channels, Inwardly Rectifying
650	0	4	_aPulmonary Artery _xdrug effects
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReceptors, Adrenergic, beta _xdrug effects
650	0	4	_aReceptors, Purinergic P1 _xdrug effects
650	0	4	_aTolbutamide _xpharmacology
650	0	4	_aVasodilation _xdrug effects
700	1		_aMcIntyre, R C
700	1		_aMeldrum, D R
700	1		_aFullerton, D A
773	0		_tThe American journal of physiology _gvol. 273 _gno. 5 _gp. L950-6
856	4	0	_uhttps://doi.org/10.1152/ajplung.1997.273.5.L950 _zAvailable from publisher's website
999			_c9344586 _d9344586